5 Years After The Chaos of COVID-19 Comes A New Era of AI Innovation

Five years ago this week, the COVID-19 pandemic threw our world into chaos. But that chaos also sparked an opportunity and a drive to accelerate innovation, through leveraging artificial intelligence with clinical knowledge in unprecedented ways. The results of these Covid-driven efforts have led to a fuller understanding of our community’s health, enabling the initiation of care further upstream and enhancing management of resources and costs in ways benefiting both patients and providers.

I can still remember that week five years ago. I had my bags packed and flight booked to travel to one of the biggest healthcare technology conferences, HIMSS, in Orlando, Fla., when the word came down. The government declared a full lockdown of the country thanks to the pernicious COVID-19 outbreak that the World Health Organization had declared a full-blown pandemic.

Sadly, the cost of COVID-19 in lives— 1.2 million deaths in the U.S. alone— was devastating and the reverberations of the pandemic still affect our daily lives.

However, the chaos and heartache also stimulated a new mindset for collaboration. While the lockdown closed our office doors, it opened new windows to collaborate with other stakeholders across our community.  Our teams immediately partnered with Dallas County Health and Human Services (DCHHS), Parkland Health (Parkland) , and other local providers and governmental agencies to help support our North Texas public health leaders and families manage through the ever-changing nature of the COVID-19 pandemic.  We deployed a transparent, data-driven set of analytics to inform the dynamic allocation of resources, guide triage protocols in emergency rooms, identify COVID-19 community hotspots, and predict rising waves of hospitalizations and capacity challenges. These collaborations would evolve into support for testing, vaccination distribution, and measuring of community-wide immunity to the infection.

While many of the solutions developed during COVID-19 were industry firsts, we continue today to leverage and expand on many of these same novel applications in AI and non-medical drivers of health (NMDoH) analytics. 

Vulnerability Index

The development of the Covid Vulnerability Index and geo-mapped hotspotting created the dynamic dashboards that guided the local pandemic response, including the placement of the testing, and later vaccination sites.  This novel approach later expanded into what’s now the Community Vulnerability Index, an industry leading NMDoH analytics method modeling community and neighborhood barriers to health and wellness.

Proximity Index

The Covid Proximity Index was used to predict the risk of infection daily at the individual level using advanced geomapping and data science techniques to guide personal awareness and behaviors, county-wide contact tracing, healthcare provider virtual care scheduling, and ED triage.  We are so proud of the United States Patent for AI driven proximity index system and methods (US 12,087,449 B2) that was awarded to PCCI late last year.  We’re now leveraging these methods alongside mobility data to understand access to vital services and placement of new access points in the community. The Proximity Index was also featured in the highly respected peer-reviewed New England Journal of Medicine Catalyst in a paper authored by Parkland’s CEO Frederick Cerise, MD and others.

Community Protection Modeling

The national Covid Community Protection Dashboard was launched in collaboration with the Institute for Healthcare Improvement (IHI), Civitas Networks for Health, and Cincinnati Children’s Hospital to model local behaviors and immunity patterns and help communities manage through new Covid variants and waves. We learned that the dynamic nature of modeling factors and a community’s protection depends on the characteristics of the most prevalent current variant and the immunity from prior vaccination and infections, adjusting for the time elapsed from the most recent immunizing event. These innovations translated into the development and deployment of the Pediatric Asthma Surveillance System (PASS), the soon to be released Diabetes/Hypertension Surveillance System, and the development of a novel Maternal Health Surveillance System. Each of the programs are (or will be) in use in Dallas County and provide life-saving support to its residents.

Better Preparedness for Future Crises

The pandemic brought Parkland, our main public health system, closer to DCHHS and many other public health leaders, working together with PCCI to build new policies and procedures to manage the COVID-19 emergency and future public health crises. And have no doubt about it, it is only a matter of when, not if, we will have more COVID-19-like outbreaks.

In the big picture for public health innovation, COVID-19 created a necessity for us to be innovative and try new ways to solve extremely difficult problems. This same way of thinking is helping us today as we tackle ongoing health challenges through improved collaborations and tools. For example, our Community Vulnerability Compass (CVC) is a tool that can provide deeps insights into the complexities of societal challenges to health, access, and community well-being affecting our neighborhoods throughout Texas. It can tell you, for example, what local daily challenges our residents face down to the block level. The CVC has been adopted by a variety of organizations around the state, led by the United Way of Metropolitan Dallas through its Data Capacity Building Initiative that, within five years, aims to equip over 200 community-based partners with robust data insights from the CVC.

And as previously mentioned, the PASS system is celebrating its two-year anniversary of providing residents of Dallas County unprecedented understanding of their vulnerability to asthma-related risks. PASS is a community-wide effort between the county, PCCI, and Parkland and is publicly available at the DCHHS website. It has been visited by thousands of Dallas County residents and was honored by the Dallas County Commissioners for its service to asthma sufferers and was described by the Dallas Morning News as “a win for Dallas County.” PASS has also been featured in the New England Journal of Medicine Catalyst.

The pandemic did put a damper on at least one of our innovations.  The book, “Building Connected Communities of Care,” was due to drop via a major release at the Orlando HIMSS convention in March, 2020.  The celebration and release was changed and conducted virtually and digitally.  This guidebook helps communities and public health leaders create holistic community networks that support any number of health management issues. Thanks to its insights and easy-to-follow steps, “Building Connected Communities of Care” has become an invaluable resource for many public health leaders across the country. It was also featured in the New England Journal of Medicine Catalyst for its insights it offers in handling community healthcare crises.

The COVID-19 pandemic was not easy on anyone, but we are wise to remember what happened during those tough times and leverage the innovations and progress towards bigger and broader ongoing impact. We will continue to leverage the critical clinical and community health lessons COVID-19 taught us in innovative programs incorporating the newest AI technology. As a community, while we remember the terrible price COVID-19 cost our friends and families, we should feel some level of optimism that the next time we will be better prepared and stronger together.

About Steve Miff

Dr. Steve Miff is the President and CEO of Parkland Center for Clinical Innovation (PCCI), a leading, research non-profit, artificial intelligence and cognitive computing organization affiliated with Parkland Health, one of the country’s largest and most progressive safety-net hospitals. Spurred by his passion to use next-generation analytics and technology to help serve the most vulnerable and underserved residents, Steve and his team focus on leveraging technology, data science, and clinical expertise to obtain unique non-medical-determinants-of-health data and incorporate those holistic, personal insights into point-of-care interventions.